S
Silke Buda
Researcher at Robert Koch Institute
Publications - 81
Citations - 2871
Silke Buda is an academic researcher from Robert Koch Institute. The author has contributed to research in topics: Medicine & Influenza A virus. The author has an hindex of 19, co-authored 74 publications receiving 2155 citations.
Papers
More filters
Journal ArticleDOI
Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis
Maria D. Van Kerkhove,Katelijn Vandemaele,Vivek Shinde,Giovanna Jaramillo-Gutierrez,Artemis Koukounari,Christl A. Donnelly,Luis O. Carlino,Rhonda Owen,Beverly Paterson,Louise Pelletier,Julie Vachon,Claudia González,Yu Hongjie,Feng Zijian,Shuk Kwan Chuang,Albert Ka-Wing Au,Silke Buda,Gérard Krause,Walter Haas,Isabelle Bonmarin,Kiyosu Taniguichi,Kensuke Nakajima,Tokuaki Shobayashi,Yoshihiro Takayama,Tomi Sunagawa,Jean-Michel Heraud,Arnaud Orelle,Ethel Palacios,Marianne A B van der Sande,C. C. H. Lieke Wielders,Darren Hunt,Jeffrey Cutter,Vernon J. Lee,Vernon J. Lee,Juno Thomas,Patricia Santa-Olalla,Maria J. Sierra-Moros,Wanna Hanshaoworakul,Kumnuan Ungchusak,Richard Pebody,Seema Jain,Anthony W. Mounts +41 more
TL;DR: This study analyzes data from 19 countries, comprising some 70,000 hospitalized patients with severe H1N1 infection, to reveal risk factors for severe pandemic influenza, which include chronic illness, cardiac disease, chronic respiratory disease, and diabetes.
Journal ArticleDOI
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
Gianfranco Spiteri,James E Fielding,Michaela Diercke,C Campese,Vincent Enouf,Alexandre Gaymard,Antonino Bella,Paola Sognamiglio,María José Sierra Moros,Antonio Nicolau Riutort,Yulia V. Demina,Romain Mahieu,Markku Broas,Malin Bengnér,Silke Buda,Julia Schilling,Laurent Filleul,Agnes Lepoutre,C. Saura,Alexandra Mailles,Daniel Lévy-Bruhl,Bruno Coignard,Sibylle Bernard-Stoecklin,Sylvie Behillil,Sylvie van der Werf,Martine Valette,Bruno Lina,Flavia Riccardo,Emanuele Nicastri,Inmaculada Casas,Amparo Larrauri,Magdalena Salom Castell,Francisco Pozo,Rinat A. Maksyutov,Charlotte Martin,Marc Van Ranst,Nathalie Bossuyt,Lotta Siira,Jussi Sane,Karin Tegmark-Wisell,Maria Palmérus,Eeva Broberg,Julien Beauté,Pernille Jorgensen,Nick Bundle,Dmitriy Pereyaslov,Cornelia Adlhoch,Jukka Pukkila,Richard Pebody,Sonja J. Olsen,Bruno Christian Ciancio +50 more
TL;DR: In the WHO European Region, COVID-19 surveillance was implemented 27 January 2020, and the first European cases are detailed, with among 38 cases studied, 21 were linked to two clusters in Germany and France, 14 were infected in China.
Journal ArticleDOI
Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012.
U Buchholz,Marcel A. Müller,Andreas Nitsche,A. Sanewski,N. Wevering,T. Bauer-Balci,F. Bonin,Christian Drosten,Brunhilde Schweiger,Thorsten Wolff,Doreen Muth,Bernhard Meyer,Silke Buda,Gérard Krause,Lars Schaade,Walter Haas +15 more
TL;DR: The contact investigation ruled out transmission to contacts after illness day 20 and the two-stage approach for serological testing may be used as a template for similar situations.
Journal ArticleDOI
Surveillance of COVID-19 school outbreaks, Germany, March to August 2020.
TL;DR: National surveillance system data on COVID-19 school outbreaks during different time periods revealed that after school closures, smaller outbreaks occurred despite low incidence in the general population.
Journal ArticleDOI
Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011.
Yanina Balabanova,Andreas Gilsdorf,Silke Buda,Reinhard Burger,Tim Eckmanns,Barbara Gärtner,Uwe Groß,Walter Haas,Osamah Hamouda,Johannes Hübner,Thomas Jänisch,Manfred Kist,Michael H. Kramer,Thomas Ledig,Martin Mielke,Matthias Pulz,Klaus Stark,Norbert Suttorp,Uta Ulbrich,Ole Wichmann,Gérard Krause +20 more
TL;DR: To establish strategic priorities for the German national public health institute (RKI) and guide the institute's mid-term strategic decisions, infectious pathogens were prioritized in accordance with their importance for national surveillance and epidemiological research.